These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 37384895)

  • 1. Surface Immobilization of Anti-VEGF Peptide on SPIONs for Antiangiogenic and Targeted Delivery of Paclitaxel in Non-Small-Cell Lung Carcinoma.
    Ngema LM; Adeyemi SA; Marimuthu T; Ubanako PN; Ngwa W; Choonara YE
    ACS Appl Bio Mater; 2023 Jul; 6(7):2747-2759. PubMed ID: 37384895
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Short Antiangiogenic MMP-2 Peptide-Decorated Conjugated Linoleic Acid-Coated SPIONs for Targeted Paclitaxel Delivery in an A549 Cell Xenograft Mouse Tumor Model.
    Ngema LM; Adeyemi SA; Marimuthu T; Ubanako PN; Ngwa W; Choonara YE
    ACS Omega; 2024 Jan; 9(1):700-713. PubMed ID: 38222506
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis of Novel Conjugated Linoleic Acid (CLA)-Coated Superparamagnetic Iron Oxide Nanoparticles (SPIONs) for the Delivery of Paclitaxel with Enhanced In Vitro Anti-Proliferative Activity on A549 Lung Cancer Cells.
    Ngema LM; Adeyemi SA; Marimuthu T; Ubanako P; Wamwangi D; Choonara YE
    Pharmaceutics; 2022 Apr; 14(4):. PubMed ID: 35456663
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Optimization, Characterization and in vivo Evaluation of Paclitaxel-Loaded Folate-Conjugated Superparamagnetic Iron Oxide Nanoparticles.
    Gui G; Fan Z; Ning Y; Yuan C; Zhang B; Xu Q
    Int J Nanomedicine; 2021; 16():2283-2295. PubMed ID: 33776433
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of biocompatible and VEGF-targeted paclitaxel nanodrugs on albumin and graphene oxide dual-carrier for photothermal-triggered drug delivery in vitro and in vivo.
    Deng W; Qiu J; Wang S; Yuan Z; Jia Y; Tan H; Lu J; Zheng R
    Int J Nanomedicine; 2018; 13():439-453. PubMed ID: 29403275
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Encapsulated paclitaxel nanoparticles exhibit enhanced anti-tumor efficacy in A549 non-small lung cancer cells.
    Huang G; Zang B; Wang X; Liu G; Zhao J
    Acta Biochim Biophys Sin (Shanghai); 2015 Dec; 47(12):981-7. PubMed ID: 26525950
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeted delivery of paclitaxel drug using polymer-coated magnetic nanoparticles for fibrosarcoma therapy: in vitro and in vivo studies.
    Al-Obaidy R; Haider AJ; Al-Musawi S; Arsad N
    Sci Rep; 2023 Feb; 13(1):3180. PubMed ID: 36823237
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Co-delivery of cisplatin and paclitaxel by folic acid conjugated amphiphilic PEG-PLGA copolymer nanoparticles for the treatment of non-small lung cancer.
    He Z; Huang J; Xu Y; Zhang X; Teng Y; Huang C; Wu Y; Zhang X; Zhang H; Sun W
    Oncotarget; 2015 Dec; 6(39):42150-68. PubMed ID: 26517524
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Co-delivery of paclitaxel and anti-VEGF siRNA by tripeptide lipid nanoparticle to enhance the anti-tumor activity for lung cancer therapy.
    Zhang C; Zhao Y; Zhang E; Jiang M; Zhi D; Chen H; Cui S; Zhen Y; Cui J; Zhang S
    Drug Deliv; 2020 Dec; 27(1):1397-1411. PubMed ID: 33096948
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Redox-sensitive carrier-free nanoparticles self-assembled by disulfide-linked paclitaxel-tetramethylpyrazine conjugate for combination cancer chemotherapy.
    Zou L; Liu X; Li J; Li W; Zhang L; Fu C; Zhang J; Gu Z
    Theranostics; 2021; 11(9):4171-4186. PubMed ID: 33754055
    [No Abstract]   [Full Text] [Related]  

  • 11. Fabrication and evaluation of aptamer-conjugated paclitaxel-loaded magnetic nanoparticles for targeted therapy on breast cancer cells.
    Khodadadi E; Mahjoub S; Arabi MS; Najafzadehvarzi H; Nasirian V
    Mol Biol Rep; 2021 Mar; 48(3):2105-2116. PubMed ID: 33635469
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of paclitaxel loaded pegylated gelatin targeted nanoparticles for improved treatment efficacy in non-small cell lung cancer (NSCLC): an in vitro and in vivo evaluation study.
    Gu M; Luan J; Song K; Qiu C; Zhang X; Zhang M
    Acta Biochim Pol; 2021 Aug; 68(4):583-591. PubMed ID: 34355554
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vivo antitumor effect of endostatin-loaded chitosan nanoparticles combined with paclitaxel on Lewis lung carcinoma.
    Xie F; Ding RL; He WF; Liu ZJ; Fu SZ; Wu JB; Yang LL; Lin S; Wen QL
    Drug Deliv; 2017 Nov; 24(1):1410-1418. PubMed ID: 28933203
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Polyethylene Glycol-Chitosan Oligosaccharide-Coated Superparamagnetic Iron Oxide Nanoparticles: A Novel Drug Delivery System for Curcumin Diglutaric Acid.
    Sorasitthiyanukarn FN; Muangnoi C; Thaweesest W; Bhuket PRN; Jantaratana P; Rojsitthisak P; Rojsitthisak P
    Biomolecules; 2020 Jan; 10(1):. PubMed ID: 31906490
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Delta-like ligand 4-targeted nanomedicine for antiangiogenic cancer therapy.
    Liu YR; Guan YY; Luan X; Lu Q; Wang C; Liu HJ; Gao YG; Yang SC; Dong X; Chen HZ; Fang C
    Biomaterials; 2015 Feb; 42():161-71. PubMed ID: 25542804
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Porous quaternized chitosan nanoparticles containing paclitaxel nanocrystals improved therapeutic efficacy in non-small-cell lung cancer after oral administration.
    Lv PP; Wei W; Yue H; Yang TY; Wang LY; Ma GH
    Biomacromolecules; 2011 Dec; 12(12):4230-9. PubMed ID: 22044456
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Peptide-functionalized and high drug loaded novel nanoparticles as dual-targeting drug delivery system for modulated and controlled release of paclitaxel to brain glioma.
    Di Mauro PP; Cascante A; Brugada Vilà P; Gómez-Vallejo V; Llop J; Borrós S
    Int J Pharm; 2018 Dec; 553(1-2):169-185. PubMed ID: 30321641
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Smart Polymeric Nanoparticles with pH-Responsive and PEG-Detachable Properties (II): Co-Delivery of Paclitaxel and VEGF siRNA for Synergistic Breast Cancer Therapy in Mice.
    Jin M; Hou Y; Quan X; Chen L; Gao Z; Huang W
    Int J Nanomedicine; 2021; 16():5479-5494. PubMed ID: 34413645
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antitumor effect of iRGD-modified liposomes containing conjugated linoleic acid-paclitaxel (CLA-PTX) on B16-F10 melanoma.
    Du R; Zhong T; Zhang WQ; Song P; Song WD; Zhao Y; Wang C; Tang YQ; Zhang X; Zhang Q
    Int J Nanomedicine; 2014; 9():3091-105. PubMed ID: 25028548
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Innovative superparamagnetic iron-oxide nanoparticles coated with silica and conjugated with linoleic acid: Effect on tumor cell growth and viability.
    Muzio G; Miola M; Ferraris S; Maggiora M; Bertone E; Puccinelli MP; Ricci M; Borroni E; Canuto RA; Verné E; Follenzi A
    Mater Sci Eng C Mater Biol Appl; 2017 Jul; 76():439-447. PubMed ID: 28482548
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.